HealthStream 향후 성장
Future 기준 점검 1/6
HealthStream은 연간 수입과 매출이 각각 10.5%와 4.9% 증가할 것으로 예상되고 EPS는 연간 10.7%만큼 증가할 것으로 예상됩니다.
핵심 정보
10.5%
이익 성장률
10.68%
EPS 성장률
| Healthcare Services 이익 성장 | 19.9% |
| 매출 성장률 | 4.9% |
| 향후 자기자본이익률 | n/a |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 21 Jul 2026 |
최근 향후 성장 업데이트
분석 기사 • Nov 06
Earnings Beat: HealthStream, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...분석 기사 • Feb 27
HealthStream, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that HealthStream, Inc. ( NASDAQ:HSTM ) filed its yearly result this time last week...Recent updates
내러티브 업데이트 • Jul 22
HSTM: Higher P/E Outlook And Capital Returns Will Support Future Upside
HealthStream's fair value estimate has been updated from $30.50 to $33.50 as analysts factor in a revised P/E outlook and recent price target increases that reflect adjusted expectations ahead of upcoming earnings. Analyst Commentary Recent Street research on HealthStream offers a mixed picture, with some analysts updating models and price targets ahead of upcoming earnings.
내러티브 업데이트 • Jun 13
HSTM: Buybacks And Updated Assumptions Will Shape Balanced Future Share Performance
Analysts have raised their price target on HealthStream by $3. They cite updated views on its fair value and revised assumptions for the discount rate, revenue growth, profit margins, and future P/E.내러티브 업데이트 • May 30
HSTM: AI Disruption Risks And Buybacks Will Shape Future Share Performance
Analysts have raised their fair value estimate for HealthStream from $21.00 to $24.00, citing updated views on the company’s discount rate, revenue growth, profit margins, and future P/E assumptions reflected in recent Street research. Analyst Commentary Street research around HealthStream has become more mixed, even as some firms lift price targets.내러티브 업데이트 • Apr 22
HSTM: AI Disruption Risks And Capital Returns Will Drive Future Share Performance
Narrative Update on HealthStream Analysts have reset their price target on HealthStream to $21 from $25, citing respectable 4Q'25 results and management's detailed response to AI-related risks. They view this as leaving the company relatively better positioned than many other SaaS peers.내러티브 업데이트 • Apr 08
HSTM: AI Risk Positioning And Capital Returns Will Support Upside Potential
Analysts have reduced the fair value estimate for HealthStream from $34.00 to $30.50, citing a lower forward P/E assumption and an increased discount rate, while also referencing recent Street research that trimmed the price target to $21 and highlighted both respectable 4Q'25 results and management's case that the company is relatively well positioned against AI-related risks in SaaS. Analyst Commentary Recent Street commentary on HealthStream focuses on how the company is handling AI related risks in SaaS and what that could mean for valuation and execution.내러티브 업데이트 • Mar 25
HSTM: AI Disruption Risks And Capital Returns Will Shape Future Outlook
Analysts have reset their price target on HealthStream to $21, down from $25, after incorporating fresh views on AI-related risks and management's argument that the company is relatively well positioned compared with other SaaS names. Analyst Commentary Bearish analysts have trimmed expectations on HealthStream by cutting the price target to $21 from $25, while maintaining a neutral stance on the shares.내러티브 업데이트 • Mar 10
HSTM: AI Risks, Capital Returns And Fair Value Will Shape Outlook
Analysts have reduced their price target on HealthStream to $21 from $25, citing a recalibration of fair value, discount rate and future P/E assumptions, while also highlighting management's view that the business model remains relatively well positioned against rising AI related concerns for SaaS names. Analyst Commentary Bearish analysts are signaling a more cautious stance on HealthStream after the latest quarterly update.내러티브 업데이트 • Feb 24
HSTM: Dividend Hike And Buyback Will Support Future Upside Potential
Analysts have kept their $25.00 price target for HealthStream unchanged, citing only slight tweaks to assumptions around the discount rate, revenue growth, profit margin, and future P/E that together do not materially shift their overall view on the stock. What's in the News The board approved a quarterly cash dividend of US$0.035 per share, a 12.9% increase from the prior US$0.031, payable on March 20, 2026, to shareholders of record on March 9, 2026 (company announcement).내러티브 업데이트 • Feb 10
HSTM: Fine Tuned Assumptions Will Support Future Upside Potential
Analysts kept their fair value estimate for HealthStream at $25.00, with modest tweaks to inputs such as discount rate, revenue growth, profit margin, and future P/E assumptions. This underpins the unchanged price target and reflects only fine tuning in their models rather than a shift in overall view.분석 기사 • Feb 07
HealthStream, Inc. (NASDAQ:HSTM) Investors Are Less Pessimistic Than Expected
HealthStream, Inc.'s ( NASDAQ:HSTM ) price-to-earnings (or "P/E") ratio of 28.8x might make it look like a sell right...내러티브 업데이트 • Jan 27
HSTM: Share Repurchases And Acquisition Efforts Will Drive Future Upside
Analysts now place their fair value estimate for HealthStream at US$25.00. The updated target reflects small tweaks to discount rate, revenue growth, profit margin, and future P/E assumptions in their models.내러티브 업데이트 • Jan 12
HSTM: Share Buybacks And M&A Activity Will Support Future Upside
Analysts have trimmed their fair value estimate for HealthStream from US$28 to about US$25. They cite updated assumptions on discount rates, revenue growth, profit margins, and a lower future P/E multiple in their refreshed models.분석 기사 • Nov 06
Earnings Beat: HealthStream, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...분석 기사 • Oct 30
A Look At The Intrinsic Value Of HealthStream, Inc. (NASDAQ:HSTM)
Key Insights Using the 2 Stage Free Cash Flow to Equity, HealthStream fair value estimate is US$29.23 With US$24.60...Seeking Alpha • Jun 04
HealthStream: High-Quality Business At A Fair Price
Summary HealthStream boasts a resilient, founder-led SaaS business model with decades of profitable growth, strong balance sheet, and shareholder-friendly capital returns. Revenue is highly recurring and predictable due to long-term, non-cancelable contracts, with built-in price escalators and industry-leading products recognized by G2. Short-term headwinds include funding cuts, customer bankruptcy, and delayed revenue recognition, prompting a downward revision in 2025 guidance, but technical issues are seen as temporary. Transition to SaaS and platform offerings positions HealthStream for higher margins and future growth, with most products tied to essential, mandatory healthcare requirements. Despite strong fundamentals, the stock remains expensive on a P/E basis but appears fairly valued on a P/S basis; thus, I rated it as HOLD overall, with a small starter position reflecting my long-term confidence in the business. Read the full article on Seeking Alpha분석 기사 • May 23
We Discuss Why The CEO Of HealthStream, Inc. (NASDAQ:HSTM) Is Due For A Pay Rise
Key Insights HealthStream's Annual General Meeting to take place on 29th of May Total pay for CEO Bobby Frist includes...분석 기사 • May 07
HealthStream (NASDAQ:HSTM) Is Doing The Right Things To Multiply Its Share Price
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...분석 기사 • Feb 27
HealthStream, Inc. Just Beat EPS By 5.1%: Here's What Analysts Think Will Happen Next
Shareholders might have noticed that HealthStream, Inc. ( NASDAQ:HSTM ) filed its yearly result this time last week...분석 기사 • Nov 28
Should You Be Adding HealthStream (NASDAQ:HSTM) To Your Watchlist Today?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...분석 기사 • Nov 07
Returns At HealthStream (NASDAQ:HSTM) Are On The Way Up
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
새로운 내러티브 • Sep 24
Navigating Temporary Challenges, The Company Sets Its Sights On Long-term Revenue Growth And Market Expansion
Expansion into the health plan market and strong sales pipelines in key products signal potential for revenue growth and customer base diversification.분석 기사 • Aug 08
HealthStream, Inc.'s (NASDAQ:HSTM) Shareholders Might Be Looking For Exit
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 17x, you may...분석 기사 • Jul 17
We Ran A Stock Scan For Earnings Growth And HealthStream (NASDAQ:HSTM) Passed With Ease
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...분석 기사 • Apr 24
HealthStream, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
It's been a good week for HealthStream, Inc. ( NASDAQ:HSTM ) shareholders, because the company has just released its...이익 및 매출 성장 예측
| 날짜 | 매출 | 이익 | 자유현금흐름 | 영업현금흐름 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2028 | 361 | N/A | 39 | N/A | 1 |
| 12/31/2027 | 343 | 24 | 42 | 84 | 5 |
| 12/31/2026 | 327 | 22 | 35 | 73 | 5 |
| 3/31/2026 | 312 | 20 | 33 | 63 | N/A |
| 12/31/2025 | 304 | 18 | 31 | 63 | N/A |
| 9/30/2025 | 299 | 21 | 29 | 61 | N/A |
| 6/30/2025 | 295 | 20 | 31 | 62 | N/A |
| 3/31/2025 | 292 | 19 | 35 | 64 | N/A |
| 12/31/2024 | 292 | 20 | 30 | 58 | N/A |
| 9/30/2024 | 288 | 20 | 32 | 60 | N/A |
| 6/30/2024 | 285 | 18 | 38 | 66 | N/A |
| 3/31/2024 | 283 | 18 | 37 | 64 | N/A |
| 12/31/2023 | 279 | 15 | 36 | 64 | N/A |
| 9/30/2023 | 277 | 13 | 31 | 58 | N/A |
| 6/30/2023 | 274 | 13 | 22 | 49 | N/A |
| 3/31/2023 | 270 | 12 | 24 | 51 | N/A |
| 12/31/2022 | 267 | 12 | 26 | 51 | N/A |
| 9/30/2022 | 263 | 9 | 24 | 49 | N/A |
| 6/30/2022 | 259 | 7 | 20 | 46 | N/A |
| 3/31/2022 | 259 | 6 | 19 | 44 | N/A |
| 12/31/2021 | 257 | 6 | 17 | 42 | N/A |
| 9/30/2021 | 254 | 7 | 18 | 42 | N/A |
| 6/30/2021 | 251 | 8 | 24 | 47 | N/A |
| 3/31/2021 | 247 | 9 | 28 | 49 | N/A |
| 12/31/2020 | 245 | 14 | 17 | 36 | N/A |
| 9/30/2020 | 246 | 17 | 26 | 44 | N/A |
| 6/30/2020 | 247 | 18 | 25 | 43 | N/A |
| 3/31/2020 | 250 | 17 | 30 | 56 | N/A |
| 12/31/2019 | 254 | 14 | N/A | 66 | N/A |
| 9/30/2019 | 251 | 14 | N/A | 67 | N/A |
| 6/30/2019 | 249 | 13 | N/A | 65 | N/A |
| 3/31/2019 | 242 | 14 | N/A | 51 | N/A |
| 12/31/2018 | 232 | 13 | N/A | 43 | N/A |
| 9/30/2018 | 227 | 13 | N/A | 40 | N/A |
| 6/30/2018 | 222 | 12 | N/A | 39 | N/A |
| 3/31/2018 | 218 | 11 | N/A | 39 | N/A |
| 12/31/2017 | 215 | 9 | N/A | 47 | N/A |
| 9/30/2017 | 218 | 5 | N/A | 45 | N/A |
| 6/30/2017 | 222 | 5 | N/A | 47 | N/A |
| 3/31/2017 | 224 | 4 | N/A | 35 | N/A |
| 12/31/2016 | 192 | 5 | N/A | 24 | N/A |
| 9/30/2016 | 223 | 6 | N/A | 24 | N/A |
| 6/30/2016 | 219 | 7 | N/A | 16 | N/A |
| 3/31/2016 | 216 | 7 | N/A | 32 | N/A |
| 12/31/2015 | 209 | 9 | N/A | 35 | N/A |
| 9/30/2015 | 198 | 9 | N/A | 31 | N/A |
애널리스트 향후 성장 전망
수입 대 저축률: HSTM 의 연간 예상 수익 증가율(10.5%)이 saving rate(3.5%)보다 높습니다.
수익 vs 시장: HSTM 의 연간 수익(10.5%)이 US 시장(16.4%)보다 느리게 성장할 것으로 예상됩니다.
고성장 수익: HSTM 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.
수익 대 시장: HSTM 의 수익(연간 4.9%)이 US 시장(연간 12.5%)보다 느리게 성장할 것으로 예상됩니다.
고성장 매출: HSTM 의 수익(연간 4.9%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.
주당순이익 성장 예측
향후 자기자본이익률
미래 ROE: HSTM의 자본 수익률이 3년 후 높을 것으로 예상되는지 판단하기에 데이터가 부족합니다.
성장 기업 찾아보기
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/07/31 04:42 |
| 종가 | 2026/07/31 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
HealthStream, Inc.는 11명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Matthew Gillmor | Baird |
| Vincent Colicchio | Barrington Research Associates, Inc. |
| Richard Close | Canaccord Genuity |